Amarastesia is a Femtech, Medtech Startup based in Switzerland with the goal to revolutionize gynecological care and to close the gap on access to care, for 60% of women living in the Rural area and with limited access to specialized care. By developing atraumatic and minimally invasive devices that are pain-free, anesthesia-free and user friendly, Amarastesia will empower family practitioners and midwives in the rural area, therefore increasing access to care for all women, globally. Our first device CerAMvix provides a pain-free and anesthesia-free uterine access for gynecological procedures with an accent in the outpatient setting. Patented technology, cerAMvix significantly improves surgical efficiency, safety and patient's comfort, reducing overall healthcare costs.
29.10.2025
Finalists revealed for three award competitions at Startup Nights (startupticker.ch)
07.10.2024
Three new ventures join DayOne Tech Accelerator in Jura (startupticker.ch)
17.03.2025
Tech4Eva Pitch Event
17.03.2025
Start-Up Ecosystem Expedition in Paris with Innosuisse
20.02.2025
2 Million Term Sheet Signed
02.02.2025
Jura Economic Promotion Funding
16.01.2025
FDA meeting, 510 K pathway
No Jobs
KOLs testimony
virtual prototype/spine surgery
virtual prototype
No Awards
Website:
www.amarastesia.com/
Headquarter:
Courroux
Foundation Date:
July 2024
Technology:
Sectors: